Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 May 6;10(5):e0125712.
doi: 10.1371/journal.pone.0125712. eCollection 2015.

Metformin versus Insulin in the Management of Pre-Gestational Diabetes Mellitus in Pregnancy and Gestational Diabetes Mellitus at the Korle Bu Teaching Hospital: A Randomized Clinical Trial

Affiliations
Randomized Controlled Trial

Metformin versus Insulin in the Management of Pre-Gestational Diabetes Mellitus in Pregnancy and Gestational Diabetes Mellitus at the Korle Bu Teaching Hospital: A Randomized Clinical Trial

Titus Beyuo et al. PLoS One. .

Abstract

Objective: To determine if metformin monotherapy or metformin in combination with insulin is equally effective as insulin monotherapy at glycemic control in diabetes mellitus in pregnancy among Ghanaians.

Methods: This was a study involving 104 pregnant women with type 2 diabetes mellitus (T2DM) or gestational diabetes mellitus (GDM) at 20-30 weeks gestation. Participants were randomized into metformin and insulin treatment groups. Starting dose of metformin was 500 mg once a day and increased gradually over two (2) weeks, to meet glycemic targets. Insulin was added if targets could not be reached on metformin alone at maximum doses. Total daily dose of premixed insulin at initiation was calculated as 0.3 IU/kg body weight and titrated upwards to achieve glycemic control. Glycemic profile monitoring was done every two weeks.

Results: The two hour post prandial blood glucose (2HPG) levels were significantly lower in the metformin group than the insulin group (p= 0.004).

Conclusion: The findings of this study suggest that metformin monotherapy is effective in achieving glycemic targets in the management of diabetes in pregnancy. It is more effective than insulin in lowering the 2HPG level.

Trial registration: Australian New Zealand Clinical Trials Registry (ANZCTR) ACTRN12614000942651.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Flow diagram of participants from enrolment to term.
Fig 2
Fig 2. Mean 2HPG levels at baseline, one month from enrolment and at term for the two treatment groups.
Fig 3
Fig 3. Mean FBG levels at baseline, one month from enrolment and at term for the two treatment groups.
Fig 4
Fig 4. Mean 1HPG levels at baseline, one month from enrolment and at term for the two treatment groups.

References

    1. WHO (2006) Definition and Diagnosis of Diabetes Mellitus and intermediate hyperglycemia. Available: http://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20... Accessed: 2014 Jul 20
    1. WHO (2013) Diagnostic Criteria and Classification of Hyperglycemia First Detected in Pregnancy. Available: http://www.who.int/diabetes/publications/Hyperglycaemia_In_Pregnancy/en Accessed: 2014 Jul 20.
    1. Ben-Haroush A, Yogev Y, Hod M (2004) Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabet Med,; 21:103–113 - PubMed
    1. Amoah AGB, Owusu SK, Adjei S (2002) Diabetes in Ghana: a community based prevalence study in Greater Accra Diabetes. Research and Clinical Practice,;56(3):197–205 - PubMed
    1. Rai L, Meenakshi D, Kamath A (2009) Metformin—a convenient alternative to insulin for Indian women with diabetes in pregnancy. J Med Sci,;63(11):491–7. 10.4103/0019-5359.58878 - DOI - PubMed

Publication types